Ga-68-Prostate-Specific Membrane Antigen PET/CT Uptake in Intraventricular Meningioma in the Choroid Plexus
Carregando...
Citações na Scopus
10
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
LIPPINCOTT WILLIAMS & WILKINS
Citação
CLINICAL NUCLEAR MEDICINE, v.46, n.1, p.58-59, 2021
Resumo
A 68-year-old man in whom a prostate cancer biochemical recurrence was being investigated was referred for a full-body Ga-68-prostate-specific membrane antigen PET/CT. Focal uptake in a lesion on the choroid plexus projection was detected. Patient had no neurological complaints. A previous MRI performed 4 years ago showed the same lesion. According to the location and radiological and clinical characteristics, the diagnosis of meningioma was defined. The interpretation of prostate-specific membrane antigen PET/CT must take into account the low frequency of metastases in sites such as the central nervous system, and the possibility of intense uptake in lesions unrelated to prostate cancer.
Palavras-chave
Ga-68-PSMA, meningioma, PET/CT scan, prostatic neoplasms, neuroimaging
Referências
- Bilgin R, 2016, CLIN NUCL MED, V41, P956, DOI 10.1097/RLU.0000000000001406
- Calabria F, 2017, REV ESP MED NUCL IMA, V36, P335, DOI 10.1016/j.remn.2016.10.002
- Galldiks N, 2017, NEURO-ONCOLOGY, V19, P1576, DOI 10.1093/neuonc/nox112
- Guermazi A, 2000, CLIN RADIOL, V55, P503, DOI 10.1053/crad.1999.0476
- Haemels M, 2020, HELL J NUCL MED, V23, P79, DOI 10.1967/s002449912007
- Hatzoglou V, 2014, J NEUROIMAGING, V24, P161, DOI 10.1111/j.1552-6569.2012.00767.x
- Jain TK, 2017, REV ESP MED NUCL IMA, V36, P133, DOI 10.1016/j.remn.2016.10.005
- Majos C, 1999, AM J NEURORADIOL, V20, P882
- McIver JI, 2003, SURG NEUROL, V60, P360, DOI 10.1016/S0090-3019(03)00157-5
- Nowosielski M, 2017, NEURO-ONCOLOGY, V19, P1588, DOI 10.1093/neuonc/nox101
- Sasikumar A, 2017, CLIN NUCL MED, V42, pE41, DOI 10.1097/RLU.0000000000001451
- Tremont-Lukats IW, 2003, CANCER-AM CANCER SOC, V98, P363, DOI 10.1002/cncr.11522
- Unterrainer M, 2019, CLIN NUCL MED, V44, P412, DOI 10.1097/RLU.0000000000002513
- Yin C, 2019, CLIN NUCL MED, V44, pE382, DOI 10.1097/RLU.0000000000002548